Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Granulomatosis with Polyangiitis × Etanercept × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vasculitis 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Metabolic Syndrome 1 Lung Neoplasms 1 Inflammation 1 Granulomatosis with Polyangiitis 1 Bone Neoplasms 1 Arthritis, Juvenile 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00005007 2007-12-28

Etanercept for Wegener's Granulomatosis

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Phase 2/3 Completed

Vasculitis, Granulomatosis with Polyangiitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡